van Heerde P - Search Results

1

Prognostic factors for treatment of malignant lymphoma in dogs.

Teske E, van Heerde P, Rutteman GR, Kurzman ID, Moore PF, MacEwen EG. Teske E, et al. Among authors: van heerde p. J Am Vet Med Assoc. 1994 Dec 15;205(12):1722-8. J Am Vet Med Assoc. 1994. PMID: 7744644 Clinical Trial.

2

Polyethylene glycol-L-asparaginase versus native L-asparaginase in canine non-Hodgkin's lymphoma.

Teske E, Rutteman GR, van Heerde P, Misdorp W. Teske E, et al. Among authors: van heerde p. Eur J Cancer. 1990;26(8):891-5. doi: 10.1016/0277-5379(90)90193-w. Eur J Cancer. 1990. PMID: 2145933 Clinical Trial.

3

Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology.

Teske E, Wisman P, Moore PF, van Heerde P. Teske E, et al. Among authors: van heerde p. Exp Hematol. 1994 Nov;22(12):1179-87. Exp Hematol. 1994. PMID: 7925781

4

DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.

Teske E, Rutteman GR, Kuipers-Dijkshoorn NJ, van Dierendonck JH, van Heerde P, Cornelisse CJ. Teske E, et al. Among authors: van dierendonck jh, van heerde p. Exp Hematol. 1993 Apr;21(4):579-84. Exp Hematol. 1993. PMID: 8462667

5

Diagnostic value and reproducibility of fine-needle aspiration cytology in canine malignant lymphoma.

Teske E, van Heerde P. Teske E, et al. Among authors: van heerde p. Vet Q. 1996 Sep;18(3):112-5. doi: 10.1080/01652176.1996.9694630. Vet Q. 1996. PMID: 8903146 Free article.

6

Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 cases.

Van Gorp J, De Bruin PC, Sie-Go DM, Van Heerde P, Ossenkoppele GJ, Rademakers LH, Meijer CJ, Van Den Tweel JG. Van Gorp J, et al. Among authors: van den tweel jg, van heerde p. Histopathology. 1995 Aug;27(2):139-48. doi: 10.1111/j.1365-2559.1995.tb00022.x. Histopathology. 1995. PMID: 8835262

7

Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance.

de Jong D, Boot H, van Heerde P, Hart GA, Taal BG. de Jong D, et al. Among authors: van heerde p. Gastroenterology. 1997 May;112(5):1466-74. doi: 10.1016/s0016-5085(97)70026-x. Gastroenterology. 1997. PMID: 9136823

8

Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma.

Noorduyn LA, van der Valk P, van Heerde P, Vroom TM, Blok P, Willemze R, Meijer CJ. Noorduyn LA, et al. Among authors: van der valk p, van heerde p. Am J Clin Pathol. 1990 Jan;93(1):49-57. doi: 10.1093/ajcp/93.1.49. Am J Clin Pathol. 1990. PMID: 2403742

9

Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept.

Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Taal BG, et al. Among authors: van heerde p. Gut. 1996 Oct;39(4):556-61. doi: 10.1136/gut.39.4.556. Gut. 1996. PMID: 8944565 Free PMC article.

10

Treatment results of primary stage I and II non-Hodgkin's lymphoma of the stomach.

Burgers JM, Taal BG, van Heerde P, Somers R, den Hartog Jager FC, Hart AA. Burgers JM, et al. Among authors: van heerde p. Radiother Oncol. 1988 Apr;11(4):319-26. doi: 10.1016/0167-8140(88)90203-4. Radiother Oncol. 1988. PMID: 3375458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters